U.S Physical Therapy Operating Expenses 2010-2024 | USPH

U.S Physical Therapy operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
U.S Physical Therapy Annual Operating Expenses
(Millions of US $)
2023 $553
2022 $496
2021 $424
2020 $371
2019 $415
2018 $394
2017 $359
2016 $307
2015 $284
2014 $259
2013 $225
2012 $211
2011 $200
2010 $178
2009 $173
U.S Physical Therapy Quarterly Operating Expenses
(Millions of US $)
2024-09-30 $153
2024-06-30 $148
2024-03-31 $141
2023-12-31 $156
2023-09-30 $134
2023-06-30 $131
2023-03-31 $132
2022-12-31 $134
2022-09-30 $125
2022-06-30 $121
2022-03-31 $117
2021-12-31 $113
2021-09-30 $109
2021-06-30 $105
2021-03-31 $97
2020-12-31 $99
2020-09-30 $89
2020-06-30 $74
2020-03-31 $109
2019-12-31 $107
2019-09-30 $100
2019-06-30 $106
2019-03-31 $101
2018-12-31 $103
2018-09-30 $98
2018-06-30 $98
2018-03-31 $95
2017-12-31 $95
2017-09-30 $90
2017-06-30 $89
2017-03-31 $85
2016-12-31 $80
2016-09-30 $76
2016-06-30 $75
2016-03-31 $75
2015-12-31 $74
2015-09-30 $72
2015-06-30 $70
2015-03-31 $68
2014-12-31 $69
2014-09-30 $66
2014-06-30 $64
2014-03-31 $60
2013-12-31 $59
2013-09-30 $56
2013-06-30 $56
2013-03-31 $54
2012-12-31 $53
2012-09-30 $53
2012-06-30 $53
2012-03-31 $53
2011-12-31 $52
2011-09-30 $51
2011-06-30 $49
2011-03-31 $48
2010-12-31 $46
2010-09-30 $45
2010-06-30 $44
2010-03-31 $44
2009-12-31 $44
2009-09-30 $44
2009-06-30 $43
2009-03-31 $42
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.368B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
Quest Diagnostics (DGX) United States $17.988B 18.23
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00